This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2oyu
From Proteopedia
|
Indomethacin-(S)-alpha-ethyl-ethanolamide bound to Cyclooxygenase-1
Overview
The modification of the nonselective nonsteroidal anti-inflammatory drug, indomethacin, by amidation presents a promising strategy for designing, novel cyclooxygenase (COX)-2-selective inhibitors. A series of, alpha-substituted indomethacin ethanolamides, which exist as, R/S-enantiomeric pairs, provides a means to study the impact of, stereochemistry on COX inhibition. Comparative studies revealed that the, R- and S-enantiomers of the alpha-substituted analogs inhibit COX-2 with, almost equal efficacy, whereas COX-1 is selectively inhibited by the, S-enantiomers. Mutagenesis studies have not been able to identify residues, that manifest the enantioselectivity in COX-1. In an effort to understand, the structural impact of chirality on COX-1 selectivity, the crystal, structures of ovine COX-1 in complexes with an enantiomeric pair of these, indomethacin ethanolamides were determined at resolutions between 2.75 and, 2.85 A. These structures reveal unique, enantiomer-selective interactions, within the COX-1 side pocket region that stabilize drug binding and, account for the chiral selectivity observed with the (S)-alpha-substituted, indomethacin ethanolamides. Kinetic analysis of binding demonstrates that, both inhibitors bind quickly utilizing a two-step mechanism. However, the, second binding step is readily reversible for the R-enantiomer, whereas, for the S-enantiomer, it is not. These studies establish for the first, time the structural and kinetic basis of high affinity binding of a, neutral inhibitor to COX-1 and demonstrate that the side pocket of COX-1, previously thought to be sterically inaccessible, can serve as a binding, pocket for inhibitor association.
About this Structure
2OYU is a Single protein structure of sequence from Ovis aries with , and as ligands. Active as Prostaglandin-endoperoxide synthase, with EC number 1.14.99.1 Full crystallographic information is available from OCA.
Reference
Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides., Harman CA, Turman MV, Kozak KR, Marnett LJ, Smith WL, Garavito RM, J Biol Chem. 2007 Sep 21;282(38):28096-105. Epub 2007 Jul 26. PMID:17656360
Page seeded by OCA on Wed Jan 23 12:56:36 2008
Categories: Ovis aries | Prostaglandin-endoperoxide synthase | Single protein | Garavito, R.M. | Harman, C.A. | BOG | HEM | IMS | Cox | Heme | Indomethacin | Nsaid | Oxidoreductase | Pghs
